• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Director Amentum Joint Venture Gp Llc disposed of 2,433,022 shares (SEC Form 4)

    5/12/25 9:07:42 AM ET
    $AMTM
    Get the next $AMTM alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Amentum Joint Venture GP LLC

    (Last) (First) (Middle)
    C/O GOLDBERG LINDSAY & CO. LLC
    630 FIFTH AVENUE, 30TH FLOOR

    (Street)
    NEW YORK NY 10111

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Amentum Holdings, Inc. [ AMTM ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    05/08/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    Form filed by One Reporting Person
    X Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 05/08/2025 J(1) 2,433,022 D $0(2) 0(1) I By Amentum Joint Venture LP(1)(2)
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    1. Name and Address of Reporting Person*
    Amentum Joint Venture GP LLC

    (Last) (First) (Middle)
    C/O GOLDBERG LINDSAY & CO. LLC
    630 FIFTH AVENUE, 30TH FLOOR

    (Street)
    NEW YORK NY 10111

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    Amentum Joint Venture LP

    (Last) (First) (Middle)
    C/O GOLDBERG LINDSAY & CO. LLC
    630 FIFTH AVENUE, 30TH FLOOR

    (Street)
    NEW YORK NY 10111

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    Explanation of Responses:
    1. This Form 4 is filed jointly by (i) Amentum Joint Venture GP LLC and (ii) Amentum Joint Venture LP ("Amentum JV"). Amentum Joint Venture GP LLC is the general partner of Amentum JV and may be deemed to have indirect voting and investment control over the shares held by Amentum JV. The shares of the Issuer reported as disposed in this Form 4 were owned directly by Amentum JV as a result of a Reverse Morris Trust transaction, with the Issuer surviving and being renamed Amentum Holdings, Inc., pursuant to the merger agreement and separation and distribution agreement, each dated as of November 20, 2023, among, in each case, Jacobs Solutions, Inc., the Issuer, Amentum Parent Holdings LLC and Amentum JV (as amended). The purpose of this Form 4 is to report that the Reporting Persons no longer beneficially own any shares of the Issuer.
    2. On May 8, 2025, Amentum JV made pro rata distributions-in-kind of all of the shares of the Issuer held by Amentum JV to each of its limited partners in accordance with the limited partnership agreement of Amentum JV. As a result, Amentum JV no longer holds, and each of the Reporting Persons no longer beneficially owns, any shares of the Issuer.
    /s/ James C. Pickel, Jr., Authorized Signatory for Amentum Joint Venture GP LLC 05/12/2025
    /s/ Eric Schondorf, Authorized Signatory for Amentum Joint Venture GP LLC 05/12/2025
    /s/ James C. Pickel, Jr., Authorized Signatory for Amentum Joint Venture GP LLC, the general partner of Amentum Joint Venture LP 05/12/2025
    /s/ Eric Schondorf, Authorized Signatory for Amentum Joint Venture GP LLC, the general partner of Amentum Joint Venture LP 05/12/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $AMTM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AMTM

    DatePrice TargetRatingAnalyst
    6/10/2025$24.00Neutral
    BofA Securities
    5/12/2025$30.00Mkt Outperform
    Citizens JMP
    4/16/2025$19.00Underweight
    Morgan Stanley
    4/15/2025$30.00Buy
    BTIG Research
    3/20/2025$21.00Neutral
    Goldman
    2/7/2025$25.00Neutral
    Cantor Fitzgerald
    1/10/2025$24.00Sector Perform
    RBC Capital Mkts
    11/21/2024$30.00Outperform
    Raymond James
    More analyst ratings